業績

• 2026年
• 2025年
• 2024年
• 2023年
• 2022年
• 2021年
• 2020年
• 2019年
• 2018年
• 2017年
• 2016年
• 2015年
• 2014年
• 2013年
• 2012年
• 2011年
• 2010年
• 2009年
• 2008年
• 2007年
• 2006年

2025年

• 原著
• 症例報告
• 総説
• その他

原著

• Hayashida S, Haruyama N, Hayashida H, Fukui A, Ohta O, Yoshitomi R, Nakayama M.

  Association between aortic valve calcification and cardiovascular events in patients with chronic kidney disease.

  Sci Rep. 2025 Oct 27;15(1):37524.

• Yamada S, Arase H, Shojima M, Ago T, Nakano T.

  Comparative validation of serum creatinine- and cystatin C-based surrogate markers for skeletal muscle mass in patients with non-dialysis chronic kidney disease.

  Ren Replace Ther 2025;11:63.

• Kitamura H, Tanaka S, Hiyamuta H, Tsuruya K, Kitazono T, Nakano T.

  Associations of Causes of Chronic Kidney Disease with Disease Progression and Mortality: Insights from the Fukuoka Kidney Disease Registry Study.

  Am J Nephrol. 2025;56(3):366-376.

• Suenaga T, Tanaka S, Kitamura H, Tsuruya K, Nakano T, Kitazono T.

  Estimated potassium intake and the progression of chronic kidney disease.

  Nephrol Dial Transplant. 2025 Jun 30;40(7):1362-1373.

• Tanaka S, Okamura K, Tanaka S, Kitamura H, Suenaga T, Tsuruya K, Kitazono T, Nakano T; Fukuoka Kidney Disease Registry (FKR) Study Collaboration Group.

  Associations between Multimorbidity and the Risks of Cardiovascular Disease Events and All-Cause Mortality in Patients with Chronic Kidney Disease.

  Am J Nephrol. 2025;56(5):605-617.

• Matsukuma Y, Tanaka S, Nakayama M, Kitamura H, Tsuruya K, Kitazono T, Nakano T.

  Association between the urinary sodium-to-potassium ratio and apparent treatment-resistant hypertension in Japanese patients with non-dialysis dependent chronic kidney disease: the Fukuoka Kidney disease Registry study.

  Hypertens Res. 2025 Aug;48(8):2163-2172.

• Okamura K, Tanaka S, Kitamura H, Suenaga T, Tsuruya K, Kitazono T, Nakano T; Fukuoka Kidney Disease Registry (FKR) Study Collaboration Group.

  Associations between Multimorbidity and the Risks of Cardiovascular Disease Events and All-Cause Mortality in Patients with Chronic Kidney Disease.

  Am J Nephrol. 2025;56(5):605-617.

• Nakano T, Kitamura H, Tsuneyoshi S, Tsuchimoto A, Torisu K, Tsujikawa H, Kawanishi H, Tsuruya K, Kitazono T.

  Predictors of encapsulated peritoneal sclerosis in patients undergoing peritoneal dialysis using neutral-pH dialysate.

  Clin Exp Nephrol 2025;29(2):212-220.

症例報告

• Nakamata Y, Nagao E, Fujisaki K.

  Pseudo-acute kidney injury caused by postprocedure bladder perforation.

  Kidney int

• Iwamura N, Matsukuma Y, Katafuchi E, Nakano Y, Tsutsumi K, Ueno Y, Tamura Y, Nakano T.

  Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction.

  CEN Case Rep. 2025 Apr;14(2):271-279.

• Iwamura N, Matsukuma Y, Tsutsumi K, Higashi N, Shomura S, Uesugi N, Hamashoji T, Arita Y, Deguchi T, Nakano T.

  Low-density lipoprotein apheresis for refractory lupus nephritis: A case demonstrating marked improvement in proteinuria, haematuria, and kidney function.

  Mod Rheumatol Case Rep. 2025 Jul 25;9(2):rxaf009.

• Iwamura N, Tsutsumi K, Yamada S, Uesugi N, Hamashoji T, Arita Y, Deguchi T, Nakano T.

  Subclinical acute tubular necrosis potentially associated with red yeast rice consumption unexpectedly detected in a patient with membranous nephropathy.

  CEN Case Rep. 2025 Aug;14(4):509-520.

• Uehara K, Yamada S, Mizuuchi Y, Kitazono T, Nakano T.

  Multiple relapses of sigmoid volvulus in a patient on automated peritoneal dialysis: the role of an elongated sigmoid colon and peritoneal dialysis as potential predisposing factors.

  CEN Case Rep. 2025 Aug;14(4):507-508.

• Yoshida Y, Ueki K, Matsukuma Y, Tsuchimoto A, Ataka E, Okamoto H, Torisu K, Hara Y, Ikeda H, Kitazono T, Nakano T.

  A case of neuron-derived neurotrophic factor-positive, syphilis-related membranous nephropathy that achieved spontaneous remission.

  CEN Case Rep. 2025 Jun;14(3):318-323.

• Ueki K, Tsuchimoto A, Matsukuma Y, Kitazono T, Nakano T.

  A case of end-stage kidney disease due to Alport syndrome diagnosed by skin biopsy after review of a renal biopsy 12 years ago.

  CEN Case Rep 2025;14(1):111-112.

総説

• Tsuchimoto A, Matsukuma Y, Ueki K, Masutani K, Nakano T.

  Telepathology in Renal Allograft Pathology: Current Trends and Future Prospects.

  Nephron. 2025;149(Suppl. 1):52-59.

その他

• Yamada S, Nakano T.

  Glomerular filtration of creatinine: expanding its clinical utility as a skeletal muscle mass index in non-dialysis CKD patients.

  Clin Exp Nephrol. 2025 Jun;29(6):872-874.